Redox (ASX:RDX) Results And Dividend Put Its Valuation Story Back In Focus

Redox earnings, dividend and acquisition plans come into focus

Redox (ASX:RDX) is back on investor radar after its full year 2026 results, an affirmed fully franked dividend and fresh comments that the company is actively assessing acquisition opportunities.

The latest update gives you a clearer picture of how Redox is using its balance sheet and cash position. It also shows how management is thinking about capital allocation between shareholder distributions and potential deals.

At a latest share price of A$3.42, Redox has had a mixed few months, with the 30 day share price return down 6.81%, the year to date share price return up 11.40%, and the 1 year total shareholder return at 47.51%. This suggests that longer term momentum has been stronger than the recent pullback.

Spot opportunities across the chemicals and industrial supply chain by comparing Redox with a hand picked list of solid balance sheet and fundamentals (22 results). This may also support consistent dividends and reinvestment capacity.

So is this pullback in Redox mainly a reset in sentiment after a strong year, or is the market starting to reassess what the recent earnings, dividend and acquisition plans are worth?

Most Popular Narrative: 14% Undervalued

At a last close of A$3.42 compared with a narrative fair value of A$3.98, the most followed Redox valuation story points to a discount based on detailed revenue, margin and P/E assumptions.

Redox continues to invest heavily in its proprietary digital ERP/CRM and logistics platforms, which drives operational efficiencies, improved customer retention, and margin enhancement. These digital initiatives should help contain costs and underpin long-term EBITDA and net margin improvement.

Read the complete narrative.

Want to see what sits behind that margin uplift story? The fair value hinges on a specific revenue growth path and a future earnings multiple that assumes those efficiency gains really stick.

Result: Fair Value of A$3.98 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, you also need to weigh risks at Redox, including cost inflation that pressures margins and a high dividend payout alongside acquisition ambitions that could stretch the balance sheet.

Find out about the key risks to this Redox narrative.

Another View on Redox valuation

The popular Redox fair value story leans on earnings and growth assumptions. The preferred earnings multiple tells a different story. At a P/E of 19.5x, Redox is slightly above the peer average of 19.3x and also above its own fair ratio of 19.2x. That points to limited margin of safety if growth or margins fall short.

Against the broader Global Trade Distributors industry at 14.5x, the premium is even clearer. You are paying more than both peers and the fair ratio that the market could move towards over time, which raises the risk that any disappointment is punished more quickly.

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

If this mix of optimism and caution around Redox leaves you undecided, spend a few minutes with the data and pressure test the assumptions yourself. A good place to start is by focusing on the 2 key rewards

Looking for more investment ideas beyond Redox?

If you like the clarity around Redox but want a broader watchlist, now is the time to widen your search before the next round of results hits.

• Target resilient balance sheets and steady fundamentals by scanning a curated list of solid balance sheet and fundamentals (22 results) that keeps financial strength front and center.
• Hunt for quality at a discount with the focused 12 high quality undervalued stocks that filters for companies where fundamentals and price are out of sync.
• Build a cash flow focused list using the income oriented 9 dividend fortresses that highlights stocks offering higher yields with support from their financials.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com